6th Jul 2005 10:59
Jupiter Asset Management Limited6 July 2005 FORM 8.3 DEALINGS BY PERSONS WHO OWN OR CONTROL 1% OR MORE OF ANY CLASS OF RELEVANT SECURITY (Rule 8.3 of The City Code on Takeovers and Mergers) Name of purchaser/vendor * JUPITER ASSET MANAGEMENT LIMITED Company dealt in TOREX RETAIL PLC Relevant security dealt in ORDINARY SHARES AND CFDs If a connected EFM, name of offeree/offeror with which connected N/A If a connected EFM, nature of connection # N/A Date of dealing 5TH JULY 2005 DEALINGS + Amount bought Price per unit (currency must be stated) 109,695 120P Amount sold Price per unit (currency must be stated) Resultant total amount and percentage of the same relevant 7,527,700 (3.937%) ORDINARY SHARESsecurity owned or controlled 1,304,400 (0.682%) CFDs IS A SUPPLEMENTAL FORM 8 (DERIVATIVE)/FORM 8 (OPTION) ATTACHED? YES Date of disclosure 6TH JULY 2005 Contact name JENNY THOMPSON Telephone number 020 7314 5565 * Specify the owner or controller in addition to the person dealing. The naming of nominees or vehicle companies is insufficient. In the case of disclosure of dealings by fund managers on behalf of discretionary clients, the clients need not be named.# See the definition of "connected fund managers and principal traders" in the Definitions Section of the Code.+ If disclosing dealings/holdings in derivatives or options, please attach Supplemental Form 8 (Derivative) or Supplemental Form 8 (Option), as appropriate. For details of the Code's dealing disclosure requirements, see Rule 8 and itsNotes which can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk. SUPPLEMENTAL FORM 8 (DERIVATIVE) DEALINGS/HOLDINGS IN DERIVATIVES (This form should be attached to Form 8.1, Form 8.1(b)(ii), Form 8.2 or Form 8.3, as appropriate) Description of all derivative products disclosed on this form CONTRACT FOR DIFFERENCE Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. NONE WRITING/ENTERING INTO A DERIVATIVE Product name Transaction Writing/entering Number of Reference Maturity eg long CFD date into (indicate securities price date as applicable) to which the (currency derivative is must be referenced stated) LONG CFD 5TH JULY 2005 ENTERED INFO 100,000 £1.11695 OPEN ENDEDLONG CFD 5TH JULY 2005 ENTERED INFO 50,000 £1.11695 OPEN ENDED CLOSING OUT A DERIVATIVE Product name Transaction Number of securities Reference Closing out price eg long CFD date to which the price (currency must be derivative is (currency stated) referenced must be stated) DETAILS OF OPEN DERIVATIVES (excluding any transaction set out above) Product name Transaction Written/entered Number of Reference Maturity eg long CFD date into (indicate securities to price date as applicable) which the (currency 25 derivative is must be referenced stated) LONG CFD 5TH MAY 2005 ENTERED INFO 100,000 £0.985985 OPEN ENDED LONG CFD 1ST AUGUST 2004 ENTERED INFO 75,000 £0.585585 OPEN ENDEDLONG CFD 23RD APRIL 2004 ENTERED INFO 164,400 £0.6006 OPEN ENDEDLONG CFD 24TH MARCH 2005 ENTERED INFO 25,000 £1.14114 OPEN ENDEDLONG CFD 9TH MARCH 2005 ENTERED INFO 30,000 £1.1011 OPEN ENDEDLONG CFD 2ND MARCH 2005 ENTERED INFO 300,000 £1.015 OPEN ENDEDLONG CFD 6TH JUNE 2005 ENTERED INFO 185,000 £1.06106 OPEN ENDEDLONG CFD 10TH JUNE 2005 ENTERED INFO 100,000 £1.00529 OPEN ENDEDLONG CFD 10TH JUNE 2005 ENTERED INFO 45,000 £1.00529 OPEN ENDEDLONG CFD 10TH JUNE 2005 ENTERED INFO 30,000 £1.00529 OPEN ENDEDLONG CFD 13TH JUNE 2005 ENTERED INFO 61,000 £0.97097 OPEN ENDEDLONG CFD 13TH JUNE 2005 ENTERED INFO 14,000 £0.97097 OPEN ENDEDLONG CFD 13TH JUNE 2005 ENTERED INFO 25,000 £0.97097 OPEN ENDED For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Tissue Regenix Group